Yes, you can sell private label coenzyme Q10 serums in the EU and the UK, but the two markets now have separate regulatory pathways following Brexit, and you must comply with each independently.
For the European Union, cosmetics are regulated under EU Cosmetics Regulation 1223/2009. Before your CoQ10 serum can be placed on the EU market, you must: (1) appoint a Responsible Person — a legal entity established within the EU who bears regulatory accountability for the product; (2) have a Cosmetic Product Safety Report (CPSR) completed by a qualified safety assessor (typically a toxicologist with EU recognition); (3) maintain a Product Information File (PIF) at the Responsible Person's address; and (4) notify the product through the EU's Cosmetic Products Notification Portal (CPNP). There is no pre-market approval from a regulator — the Responsible Person self-declares compliance — but the documentation burden is significant. CPSR costs typically run $800 to $2,500 per SKU. EU notification via CPNP is free once the Responsible Person account is set up.
For Great Britain (England, Scotland, Wales), cosmetics are now regulated under the UK Cosmetics Regulation (retained and amended from EU law), administered by the Office for Product Safety and Standards (OPSS). You need a separate UK Responsible Person — a legal entity established in Great Britain — and must notify the product through the UK's Submit Cosmetic Product Notifications (SCPN) portal. Northern Ireland remains under EU Cosmetics Regulation 1223/2009 via the Windsor Framework, meaning a separate EU RP is still required for Northern Ireland market access.
CoQ10 itself (ubiquinone and ubiquinol) is not on the EU's prohibited or restricted substances list as of 2024 and has a long history of cosmetic use, so there is no specific ingredient-level barrier for EU or UK market access.
Restricted ingredients to watch in your broader formula when selling into these markets: certain preservatives (e.g., methylisothiazolinone is restricted at 0.0015% in leave-on products in the EU), certain fragrance allergens require label disclosure above 0.001% in leave-on products under EU Cosmetics Regulation, and colorants must appear on the EU's positive list (Annex IV).
Timeline reality: securing a Responsible Person, completing a CPSR, and processing CPNP notification realistically adds 6 to 12 weeks to your EU launch timeline beyond U.S. launch readiness. Some U.S.-based contract manufacturers have EU Responsible Person partners built into their service offering — ask about this early, before you've finalized your formula, because the CPSR assessor may require adjustments to the formula or claims before signing off.
AJ Cosmo Labs lets you specify your regulatory market — U.S., EU, UK, or multiple — directly in your product brief so that manufacturers who respond already understand the compliance scope you're working within.
Ingredients in this answer: Coenzyme Q10
Read the full guide on Private Label CoQ10 Serum Manufacturer – Low MOQ →